Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Fraga

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Chemmedchem|August 26, 2015
LASSBio-1829 Hydrochloride: Development of a New Orally Active N-Acylhydrazone IKK2 Inhibitor with Anti-inflammatory PropertiesIsabella A Guedes, Rosana H C N Freitas, Natália M Cordeiro, et al.
American Journal of Hypertension|December 5, 2009
Pharmacological characterization of (3-thienylidene)-3,4-methylenedioxybenzoylhydrazide: a novel muscarinic agonist with antihypertensive profileGisele Zapata-Sudo, Sharlene L Pereira, Hellen J V Beiral, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Microwave-assisted synthesis and structure-activity relationships of neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivativesNailton M Nascimento-Júnior, Thaiana C F Mendes, Daniella M Leal, et al.
Plos One|October 12, 2012
Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α productionRenata B Lacerda, Leandro L da Silva, Cleverton K F de Lima, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 26, 2003
Dopaminergic profile of new heterocyclic N-phenylpiperazine derivativesG Neves, R Fenner, A P Heckler, et al.
Bioorganic & Medicinal Chemistry|October 2, 2007
Studies toward the structural optimization of new brazilizone-related trypanocidal 1,3,4-thiadiazole-2-arylhydrazone derivativesSamir A Carvalho, Francisco A S Lopes, Kelly Salomão, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2010
Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294Emmanuel O Carneiro, Carolina H Andrade, Rodolpho C Braga, et al.
Frontiers in Pharmacology|June 20, 2019
Evaluation of Functional Selectivity of Haloperidol, Clozapine, and LASSBio-579, an Experimental Compound With Antipsychotic-Like Actions in Rodents, at G Protein and Arrestin Signaling Downstream of the Dopamine D<sub>2</sub> ReceptorRafaela R Silva, Lucas T Parreiras-E-Silva, Thais E T Pompeu, et al.
Chirality|May 1, 2012
Synthesis and characterization of the atropisomeric relationships of a substituted N-phenyl-bipyrazole derivative with anti-inflammatory propertiesMarcia P Veloso, Nelilma C Romeiro, Gilberto M S Silva, et al.
European Journal of Pharmacology|December 22, 2007
CNS-selective noncompetitive cholinesterase inhibitors derived from the natural piperidine alkaloid (-)-spectalineNewton G Castro, Rodrigo S Costa, Luisa S B Pimentel, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Chemmedchem|August 26, 2015
LASSBio-1829 Hydrochloride: Development of a New Orally Active N-Acylhydrazone IKK2 Inhibitor with Anti-inflammatory PropertiesIsabella A Guedes, Rosana H C N Freitas, Natália M Cordeiro, et al.
American Journal of Hypertension|December 5, 2009
Pharmacological characterization of (3-thienylidene)-3,4-methylenedioxybenzoylhydrazide: a novel muscarinic agonist with antihypertensive profileGisele Zapata-Sudo, Sharlene L Pereira, Hellen J V Beiral, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Microwave-assisted synthesis and structure-activity relationships of neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivativesNailton M Nascimento-Júnior, Thaiana C F Mendes, Daniella M Leal, et al.
Plos One|October 12, 2012
Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α productionRenata B Lacerda, Leandro L da Silva, Cleverton K F de Lima, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 26, 2003
Dopaminergic profile of new heterocyclic N-phenylpiperazine derivativesG Neves, R Fenner, A P Heckler, et al.
Bioorganic & Medicinal Chemistry|October 2, 2007
Studies toward the structural optimization of new brazilizone-related trypanocidal 1,3,4-thiadiazole-2-arylhydrazone derivativesSamir A Carvalho, Francisco A S Lopes, Kelly Salomão, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2010
Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294Emmanuel O Carneiro, Carolina H Andrade, Rodolpho C Braga, et al.
Frontiers in Pharmacology|June 20, 2019
Evaluation of Functional Selectivity of Haloperidol, Clozapine, and LASSBio-579, an Experimental Compound With Antipsychotic-Like Actions in Rodents, at G Protein and Arrestin Signaling Downstream of the Dopamine D<sub>2</sub> ReceptorRafaela R Silva, Lucas T Parreiras-E-Silva, Thais E T Pompeu, et al.
Chirality|May 1, 2012
Synthesis and characterization of the atropisomeric relationships of a substituted N-phenyl-bipyrazole derivative with anti-inflammatory propertiesMarcia P Veloso, Nelilma C Romeiro, Gilberto M S Silva, et al.
European Journal of Pharmacology|December 22, 2007
CNS-selective noncompetitive cholinesterase inhibitors derived from the natural piperidine alkaloid (-)-spectalineNewton G Castro, Rodrigo S Costa, Luisa S B Pimentel, et al.
Pageof 12